INmune Bio, Inc. (NASDAQ:INMB) Q4 2025 Earnings Call Transcript March 30, 2026
INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.26.
Operator: Greetings, and welcome to the INmune Bio’s 2025 Fourth Quarter and Year-End Earnings Call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this time, it is now my pleasure to introduce Mr. Daniel Carlson, Head of Investor Relations of...
